Jorgensen, DK
Agnes Jorgensen, Slagelse DK
Patent application number | Description | Published |
---|---|---|
20110068284 | Control Valve - The control valve according to the invention is for use in liquid carrying systems. It comprises a valve housing ( | 03-24-2011 |
Allan Holm Jorgensen, Aalborg DK
Patent application number | Description | Published |
---|---|---|
20100308585 | APPARATUS AND METHOD FOR CONTROLLING THE REACTIVE POWER FROM A CLUSTER OF WIND TURBINES CONNECTED TO A UTILITY GRID - The present invention relates to a method for increasing a total reactive power capability of a cluster of wind turbines operationally connected to a grid. The method comprises the steps of generating a voltage value representative of a grid voltage level, determining a total required reactive power value based on the voltage value, and activating at least one wind turbine in said cluster to increase the total reactive power capability from a present value to the required total reactive power value by a predetermined amount. Moreover, the present invention relates to a system suitable for carrying out the before-mentioned method. | 12-09-2010 |
20120268081 | DIRECT POWER AND STATOR FLUX VECTOR CONTROL OF A GENERATOR FOR WIND ENERGY CONVERSION SYSTEM - A method for controlling a variable speed wind turbine generator is disclosed. The generator is connected to a power converter comprising switches. The generator comprises a stator and a set of terminals connected to the stator and to the switches of the power converter. The method comprises: determining a stator flux reference value corresponding to a generator power of a desired magnitude, determining an estimated stator flux value corresponding to an actual generator power, determining a difference between the determined stator flux reference value and the estimated stator flux value, and operating said switches in correspondence to the determined stator flux reference value and the estimated stator flux value to adapt at least one stator electrical quantity to obtain said desired generator power magnitude. | 10-25-2012 |
20130009611 | DIRECT POWER AND STATOR FLUX VECTOR CONTROL OF A GENERATOR FOR WIND ENERGY CONVERSION SYSTEM - A method for controlling a variable speed wind turbine generator is disclosed. The generator is connected to a power converter comprising switches. The generator comprises a stator and a set of terminals connected to the stator and to the switches of the power converter. The method comprises: determining a stator flux reference value corresponding to a generator power of a desired magnitude, determining an estimated stator flux value corresponding to an actual generator power, determining a difference between the determined stator flux reference value and the estimated stator flux value, and operating said switches in correspondence to the determined stator flux reference value and the estimated stator flux value to adapt at least one stator electrical quantity to obtain said desired generator power magnitude. | 01-10-2013 |
Allan Holm Jorgensen, Aalborg O DK
Patent application number | Description | Published |
---|---|---|
20090206606 | Variable Speed Wind Turbine Configured For Wind Farm Operation - The present invention relates to an improved wind turbine, of the type which employs doubly fed induction generators (DFIG), and a wind park including the same, which permits the use of lighter weight turbines, with the ability to have greater energy capture, more precise control of asymmetrical phases and enhanced maintenance and support of the grid during fault conditions. | 08-20-2009 |
20130147442 | Direct power and stator flux vector control of a generator for wind energy conversion system - A method for controlling a variable speed wind turbine generator is disclosed. The generator is connected to a power converter comprising switches. The generator comprises a stator and a set of terminals connected to the stator and to the switches of the power converter. The method comprises: determining a stator flux reference value corresponding to a generator power of a desired magnitude, determining an estimated stator flux value corresponding to an actual generator power, determining a difference between the determined stator flux reference value and the estimated stator flux value, and operating said switches in correspondence to the determined stator flux reference value and the estimated stator flux value to adapt at least one stator electrical quantity to obtain said desired generator power magnitude. | 06-13-2013 |
Anders Michael Jorgensen, Hillerod DK
Patent application number | Description | Published |
---|---|---|
20110208372 | POWER GENERATION SYSTEM AND METHOD OF OPERATING A POWER GENERATION SYSTEM - The present invention relates to a power generation system PGS comprising—a system intermediate output SIO, —a central controller CC, and—at least two DC/DC converters DD | 08-25-2011 |
Anders Nuchnua Jorgensen, Kobenhavn N DK
Patent application number | Description | Published |
---|---|---|
20120212344 | SYSTEM AND METHOD FOR MOTIVATING OR PROMPTING HAND WASHING - The invention relates to a system and method for motivating or prompting persons to wash hands. The system includes a sensor for detecting use of a toilet or a urinal, which sensor creates a first signal indicative of that use, and a signaling arrangement for issuing in response to the first signal at least one second signal reminding or prompting the person to use a cleansing agent dispenser. | 08-23-2012 |
Anders Steen Jorgensen, Vilby J DK
Patent application number | Description | Published |
---|---|---|
20140170293 | Concentrate Derived from a Milk Product Enriched in Naturally Occurring Sialyllactose and a Process for Preparation Thereof - A concentrate derived from milk or a milk product comprising sialyllactose in amounts higher than the normal amounts found in the milk or milk product and a process for preparation of such a concentrate by ultrafiltration and diafiltration using a thin film polyamide based membrane. The concentrate is suited for use in nutritional products. | 06-19-2014 |
Anders Steen Jorgensen, Arhus C DK
Patent application number | Description | Published |
---|---|---|
20090202449 | USE OF OSTEOPONTIN IN DENTAL FORMULATIONS - Use of osteopontin for reducing plaque bacterial growth on tooth enamel and dental formulations containing osteopontin. | 08-13-2009 |
Anker Steen Jorgensen, Copenhagen DK
Patent application number | Description | Published |
---|---|---|
20090124598 | PHARMACEUTICAL USE OF SUBSTITUTED AMIDES - The use of substituted amides for modulating the activity of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) and the use of these compounds as pharmaceutical compositions, are described. Also a novel class of substituted amides, their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds are modulators and more specifically inhibitors of the activity of 11βHSD1 and may be useful in the treatment of a range of medical disorders where a decreased intracellular concentration of active glucocorticoid is desirable. | 05-14-2009 |
Anker Steen Jorgensen, Kobenhavn DK
Patent application number | Description | Published |
---|---|---|
20100120743 | 11Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds - A novel class of compounds of the general formula (I), their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds modulate the activity of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) and are accordingly useful in the treatment of diseases in which such a modulation is beneficial, e.g. the metabolic syndrome. | 05-13-2010 |
Arne Lund Jorgensen, Hojbjerg DK
Patent application number | Description | Published |
---|---|---|
20100138940 | TRANSGENIC PIG AS A MODEL OF ALZHEIMER'S DISEASE - The present invention relates to a modified pig as a model for studying Alzheimer's disease. The modified pig model displays one or more phenotypes associated with Alzheimer's disease. Disclosed is also a modified pig comprising a modified human and/or porcine APP gene, and/or PS1 gene, and/or a transcriptional and/or translational product or part thereof. The invention further relates to methods for producing the modified pig; and methods for evaluating the effect of a therapeutical treatment of Alzheimer's disease; methods for screening the efficacy of a pharmaceutical composition; and a method for treatment of a human being suffering from Alzheimer's disease are disclosed. | 06-03-2010 |
Charlotte Levin Tykjaer Jorgensen, Copenhagen DK
Patent application number | Description | Published |
---|---|---|
20140037620 | Methods of Treating Breast Cancer with Gemcitabine Therapy - The application describes methods for predicting overall survival in subjects with breast cancer. The application also describes for screening subjects with breast cancer to determine if the breast cancer will be responsive to a breast cancer therapy including gemcitabine. The application further describes methods for treating subjects with breast cancer by screening them for the likelihood of the effectiveness of treating the cancer with a therapy including gemcitabine and administering the therapy in subjects when it is found that gemcitabine is likely to be effective. | 02-06-2014 |
Christel Thea Jorgensen, Kgs Lyngy DK
Patent application number | Description | Published |
---|---|---|
20080311242 | VARIANT LIPOLYTIC ENZYMES - The inventors have developed improved polypeptides by substituting or deleting specified amino acids in fungal lipolytic enzymes. More particularly, the polypeptides result in a reduction of dough stickiness when they are added to a dough. The polypeptides may particularly have activity on polar lipids. | 12-18-2008 |
Christel T. Jorgensen, Kgs Lyngby DK
Patent application number | Description | Published |
---|---|---|
20080293120 | LIPOLYTIC ENZYMES VARIANTS - The inventors have developed improved polypeptides by substituting or deleting specified amino acids in fungal lipolytic enzymes. More particularly, the polypeptides result in a reduction of dough stickiness when they are added to a dough. The polypeptides may particularly have activity on polar lipids. | 11-27-2008 |
20100047388 | Lipolytic Enzyme Variants - The inventors have developed improved polypeptides by substituting or deleting specified amino acids in fungal lipolytic enzymes. More particularly, the polypeptides result in a reduction of dough stickiness when they are added to a dough. The polypeptides may particularly have activity on polar lipids. | 02-25-2010 |
Christel Thea Jorgensen, Lyngby DK
Patent application number | Description | Published |
---|---|---|
20100183766 | CGTASE VARIANTS - The inventors have developed a method of modifying the amino acid sequence of a CGTase to obtain variants. The variants may form linear oligosaccharides as an initial product by starch hydrolysis and a reduced amount of cyclodextrin and may be useful for anti-staling in baked products. The method is based on a comparison of three-dimensional (3D) structures of the CGTase with the structure of a maltogenic alpha-amylase where one or both models includes a substrate. The invention also provides novel CGTase variants. | 07-22-2010 |
20120141630 | Screening Method - Lipolytic enzymes which improve the properties of dough or baked products generally have a high activity towards lipids which are capable of forming a hexagonal phase, and a screening method was developed on this basis. The improved properties may include a larger loaf volume, an improved shape factor, an improved crumb structure, reduced dough stickiness, improved dough stability and/or improved tolerance towards extended proofing. The advantageous lipid-degrading enzymes have higher activity towards MGDG and/or unsaturated phosphatidyl ethanolamines (APE, PE) than towards DGDG, PC, PS, PI, PG, saturated phosphatidyl ethanolamines, ALPE and/or triglicerides. | 06-07-2012 |
20130045302 | Screening Method - Lipolytic enzymes which improve the properties of dough or baked products generally have a high activity towards lipids which are capable of forming a hexagonal phase, and a screening method was developed on this basis. The improved properties may include a larger loaf volume, an improved shape factor, an improved crumb structure, reduced dough stickiness, improved dough stability and/or improved tolerance towards extended proofing. | 02-21-2013 |
20130337111 | Screening Method - Lipolytic enzymes which improve the properties of dough or baked products generally have a high activity towards lipids which are capable of forming a hexagonal phase, and a screening method was developed on this basis. The improved properties may include a larger loaf volume, an improved shape factor, an improved crumb structure, reduced dough stickiness, improved dough stability and/or improved tolerance towards extended proofing. | 12-19-2013 |
Christel Thea Jorgensen, Kobenhavn DK
Patent application number | Description | Published |
---|---|---|
20130178408 | Alpha-Amylase Variants - The invention relates to a variant of a parent Termamyl-like alpha-amylase, which variant exhibits altered properties, in particular reduced capability of cleaving a substrate close to the branching point, and improved substrate specificity and/or improved specific activity relative to the parent alpha-amylase. | 07-11-2013 |
20140322795 | Alpha-Amylase Variants - The invention relates to a variant of a parent Termamyl-like alpha-amylase, which variant exhibits altered properties, in particular reduced capability of cleaving a substrate close to the branching point, and improved substrate specificity and/or improved specific activity relative to the parent alpha-amylase. | 10-30-2014 |
Christel Thea Jorgensen, Kobenhavn O DK
Patent application number | Description | Published |
---|---|---|
20090155882 | Alpha-Amylase Variants - The invention relates to a variant of a parent Termamyl-like alpha-amylase, which variant exhibits altered properties, in particular reduced capability of cleaving a substrate close to the branching point, and improved substrate specificity and/or improved specific activity relative to the parent alpha-amylase. | 06-18-2009 |
20110076741 | ALPHA-AMYLASE VARIANTS - The invention relates to a variant of a parent Termamyl-like alpha-amylase, which variant exhibits altered properties, in particular reduced capability of cleaving a substrate close to the branching point, and improved substrate specificity and/or improved specific activity relative to the parent alpha-amylase. | 03-31-2011 |
Christian Isak Jorgensen, Bagsvaerd DK
Patent application number | Description | Published |
---|---|---|
20080248530 | Use of Fungal Mutants for Expression of Antibodies - The present invention relates to a filamentous fungal cell in which an endogenous alkaline protease activity, an endogenous neutral metalloprotease activity and an endogenous serine protease activity of the subtilisin type have been completely or partially inactivated. Particularly the endogenous alkaline protease activity, the endogenous neutral metalloprotease activity and the endogenous serine protease activity of the subtilisin type are encoded by the alp, npI and pepC genes respectively. The filamentous fungal cell is particularly suitable for production of heterologous proteins such as antibodies. | 10-09-2008 |
20090217464 | DETERGENT COMPOSITION COMPRISING LIPASE - The invention provides detergent compositions comprising lipolytic enzyme variants having improved in-detergent stability. Lipolytic enzyme variants with improved in-detergent stability are obtained by substituting certain specified amino acid residues in a parent lipolytic enzyme. | 09-03-2009 |
20090221034 | Lipolytic Enzyme Variant With Improved Stability And Polynucleotides Encoding Same - The invention provides lipolytic enzyme variants having improved in-detergent stability and polynucleotides encoding same. Lipolytic enzyme variants with improved in-detergent stability are obtained by substituting certain specified amino acid residues in a parent lipolytic enzyme. | 09-03-2009 |
20110078829 | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same - The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. | 03-31-2011 |
20120185971 | POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME - The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. | 07-19-2012 |
20130045506 | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same - The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. | 02-21-2013 |
20130122545 | Polypeptides Having Protease Activity and Polynucleotides Encoding Same - The present invention relates to isolated polypeptides having protease activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides. | 05-16-2013 |
20130217078 | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same - The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. | 08-22-2013 |
20140115740 | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same - The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. | 04-24-2014 |
20140295493 | Polypeptides Having Protease Activity and Polynucleotides Encoding Same - The present invention relates to isolated polypeptides having protease activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides. | 10-02-2014 |
Claus Jorgensen, Frederiksberg DK
Patent application number | Description | Published |
---|---|---|
20090101415 | Apparatus, method, computer program and user interface for enabling user input - An apparatus including a touch sensitive input device configured to provide an output dependent upon an actuated area; and a processor configured to receive inputs from the touch sensitive input device; wherein the processor is configured to detect a change in orientation of an actuated area and, in response to the detection of the change in orientation, perform a function. | 04-23-2009 |
20100295801 | ELECTRONIC DEVICES - A user interface for receiving touch user input to control an electronic apparatus, wherein the user interface is arranged to detect one or more touch input commands to control the activation and/or deactivation of one or more respective physical operations and/or modes of a particular physical operation of the electronic apparatus. | 11-25-2010 |
Claus H. Jorgensen, Bronshoj DK
Patent application number | Description | Published |
---|---|---|
20130130756 | Portable Electronic Device - A portable electronic device including a first section, a second section and a connecting section. The first section has a user input section and a first tubular housing member. The first tubular housing member forms a majority of opposite exterior lateral sides of the first section. The second section has a display and a second tubular housing member. The second tubular housing member forms a majority of opposite exterior lateral sides of the second section. The connecting section movably connects the second section with the first section. The first tubular housing member at least partially houses the user input section. The second tubular housing member at least partially houses the display. | 05-23-2013 |
20140073374 | Portable Electronic Device - A portable electronic device including a first section, a second section and a connecting section. The first section has a user input section and a first tubular housing member. The first tubular housing member forms a majority of opposite exterior lateral sides of the first section. The second section has a display and a second tubular housing member. The second tubular housing member forms a majority of opposite exterior lateral sides of the second section. The connecting section movably connects the second section with the first section. The first tubular housing member at least partially houses the user input section. The second tubular housing member at least partially houses the display. | 03-13-2014 |
Claus H. Jorgensen, Frederiksberg DK
Patent application number | Description | Published |
---|---|---|
20110007892 | Portable Electronic Device - A portable electronic device including a first section, a second section and a connecting section. The first section has a user input section and a first tubular housing member. The first tubular housing member forms a majority of opposite exterior lateral sides of the first section. The second section has a display and a second tubular housing member. The second tubular housing member forms a majority of opposite exterior lateral sides of the second section. The connecting section movably connects the second section with the first section. The first tubular housing member at least partially houses the user input section. The second tubular housing member at least partially houses the display. | 01-13-2011 |
Claus Hersum Jorgensen, Frederiksberg DK
Patent application number | Description | Published |
---|---|---|
20100331062 | Microslide - An apparatus includes a device body and a movable element slidingly engaged with the device body, the movable element being movable in a longitudinal direction between an open position and a closed position relative to the device body, wherein moving the movable element from the closed position to the open position engages an active state of the apparatus. | 12-30-2010 |
Dennis Thykjær Jorgensen, Ronde DK
Patent application number | Description | Published |
---|---|---|
20120154759 | Color-Combining Illumination Device - The present invention relates to an illumination device comprising a first light source array comprising at least a first light source; said first light source generates a first light beam having a first spectral distribution; said first light beam propagates primarily in a first direction along an optical axis; a second light source array comprising at least a second light source, said second light source generates a second light beam having a second spectral distribution; at least a first dichroic reflector positioned at least partially in said first light beam and said second light beam; said first dichroic reflector transmits at least a part of said first light beam and reflects at least a part of said second light beam; that said second light beam propagates in a second direction towards at least a part of said first light source array and at least substantially opposite to said first direction; that at least a part of said second light beam propagates primarily in said first direction after being reflected by said at least first dichroic reflector. | 06-21-2012 |
20120320102 | Projecting Illumination Device With Multiple Light Sources - The present invention relates to an illumination device illuminating an optical gate and projecting an image of the optical gate towards a target surface. The illumination device comprises a light source module generation light, an aperture delimiting the optical gate and a projecting system adapted to image the optical gate at a target surface. The light source module comprises a number of light sources and a number of light collecting means. The light collecting means comprise a central lens aligned along and a peripheral lens at least partially surrounding the central lens. The central lens collects and converts a first part of the light from the light source images the light source between the aperture the projecting system. The peripheral lens part collects and converts a second part of said light from said light source and is adapted to concentrate said second part of said light at said aperture. | 12-20-2012 |
Flemming Jorgensen, Lyngby DK
Patent application number | Description | Published |
---|---|---|
20080254058 | Pharmaceutical Composition Comprising a Bacterial Cell Displaying a Heterologous Proteinaceous Compound - The present invention pertains to a composition for the manufacture of a medicament comprising living or dead bacteria with controlled amounts of surface-coupled proteins or proteinaceous compounds and a method for the preparation of the composition. The bacterium provides a multivalent heterologous protein display vehicle that may be used in the manufacture of vaccines or medicaments for delivery via the mucosa. | 10-16-2008 |
Gert Jorgensen, Grasten DK
Patent application number | Description | Published |
---|---|---|
20090185948 | CONTAINER WITH CONTROLLED ATMOSPHERE - A container having a plurality of walls, and at least one inlet and/or outlet, said container including an apparatus for controlling the composition of gases within the container, the apparatus including at least one sensor, at least one controller and at least one gas permeable membrane, through which membrane different gases can pass at different rates, said membrane dividing the container into a first region being for holding cargo and a second region defining a gas buffer region, and said membrane being permeable permitting for nitrogen, oxygen and carbon dioxide at different flow rates, wherein the buffer region is in communication with the ambient atmosphere through one or more vacuum pump(s). | 07-23-2009 |
Gert Jorgensen, Aabenraa DK
Patent application number | Description | Published |
---|---|---|
20080202262 | GAS PERMEABLE MEMBRANE - A gas permeable membrane comprising a thin polymeric coating on a microporous backing, said gas permeable membrane being permeable permitting for oxygen and carbon dioxide at different flow rates, wherein the gas permeable membrane is made from a copolymer of a polyether and a polyamide enables the achievement of a controlled atmosphere in a cargo region, wherein the membrane is able to obtain and hold low concentrations of carbon dioxide and of oxygen in the atmosphere in the cargo region and to produce an “ideal” or optimum storage atmosphere which will ensure a retardation of respiratory activity within the container. | 08-28-2008 |
Hans Erik Jorgensen, Ishoj DK
Patent application number | Description | Published |
---|---|---|
20080272205 | Drive System for a Cleaning Head Disposed in a Tank - When, according to the invention, constructing a drive system for rotating the cleaning head in a tank and allowing the system to comprise a hysteresis coupling having two magnetic parts which are present inside the liquid space ( | 11-06-2008 |
20090320890 | Cleaning Head - When, according to the invention, a cleaning head is provided with a hysteresis coupling ( | 12-31-2009 |
Ivan Jorgensen, Smorum DK
Patent application number | Description | Published |
---|---|---|
20090041260 | Active noise cancellation in hearing devices - Disclosed is a hearing device system comprising at least one hearing aid circuitry and at least one active noise cancellation unit, the at least one hearing aid circuitry comprises at least one input transducer adapted to convert a first audio signal to an electric audio signal; a signal processor connected to the at least one input transducer and adapted to process said electric audio signal by at least partially correcting for a hearing loss of a user; an output transducer adapted to generate from at least said processed electric audio signal a sound pressure in an ear canal of the user, whereby the generated sound pressure is at least partially corrected for the hearing loss of the user; the at least one active noise cancellation unit being adapted to provide an active noise cancellation signal adapted to perform active noise cancellation of an acoustical signal entering the ear canal in addition to said generated sound pressure, wherein the hearing device system further comprises a combiner unit adapted to combine the processed electric audio signal with the active noise cancellation signal, to obtain a combined signal and to provide the combined signal to the output transducer. | 02-12-2009 |
Jeanette Moller Jorgensen, Odense DK
Patent application number | Description | Published |
---|---|---|
20090186397 | Product - The invention relates to a microorganism growth substrate which comprises a sterile nutrient composition derived from the biomass of a culture of bacteria including methanotrophic bacteria and further containing at least one sterile nutrient. A preferred biomass material is that derived from a microbial culture comprising | 07-23-2009 |
Jensen Jorgensen, Kobenhavn DK
Patent application number | Description | Published |
---|---|---|
20120188753 | DUAL CHARGING SYSTEM - The invention relates to a dual charging system comprising a rechargeable unit and a charging station. The charging station comprises retaining means and a base part, said base part having a charging seat with a projecting peg acting as a first electrode, around which an at least partly circumferential second electrode is arranged. The rechargeable unit comprises a notch, acting as a third electrode, and a fourth electrode, said third and fourth electrode is each arranged on the rechargeable unit to engage with the first and second electrode respectively of the charging seat when the rechargeable element is retained in the charging station. Hereby an advantageous charging system is achieved ensuring correct positioning of the rechargeable unit in the charging station, even under unfavourable conditions. | 07-26-2012 |
20120218744 | FLASHLIGHT WITH LIGHT FOCUSING SYSTEM - A flashlight includes a housing having a hollow interior bound by a chamber wall having opposed inner and outer surfaces, a lens carried by the housing opposing the hollow interior, a light source supported by a light source support in the hollow interior, and a focusing assembly for moving the light source relative to the lens in a longitudinal motion including a button slidably arranged on the outer surface of the chamber wall in magnetic communication with an opposed sliding member connected to the light source support in the hollow interior and which is slidably arranged on the inner surface of the chamber wall. | 08-30-2012 |
Jesper R. Jorgensen, Frederiksberg DK
Patent application number | Description | Published |
---|---|---|
20130267464 | THERAPEUTIC USE OF A GROWTH FACTOR, METRNL - The present invention relates to the field of therapeutic use of proteins, genes and cells, in particular to the therapy based on the biological function of a secreted therapeutic protein, METRNL, in particular for the treatment of disorders of the nervous system. METRNL is a Nerve Survival and Growth factor with neuroprotective and/or neurogenesis effects. | 10-10-2013 |
Jesper Roland Jorgensen, Frederiksberg C DK
Patent application number | Description | Published |
---|---|---|
20080260702 | Treatment of Retinopathies Using Gfra3 Agonists - The present invention relates to the use of GFRα3 agonists for the treatment of disorders of the retina. A preferred GFRα3 agonist is Neublastin. Neublastin may be administered to the eye using protein formulations, in vivo or ex vivo gene therapy, or implantation of encapsulated cells delivering Neublastin locally to the retina. | 10-23-2008 |
Kai Jorgensen, Copenhagen DK
Patent application number | Description | Published |
---|---|---|
20090131917 | Vapor Hydrated Catheter Assembly and Method of Making Same - A catheter assembly and method is disclosed which comprises a catheter having a coating on at least a part of its length intended to produce a low-friction surface on the catheter when treated with an activating substance in the form of a vapor. The catheter assembly also includes a catheter package forming an interior space divided by a gas permeable, liquid impermeable barrier into a first cavity and a second cavity. The first cavity of the catheter package accommodates the catheter therein and the second cavity accommodates at least a quantity of liquid in its liquid phase therein. The liquid in the second cavity can change phase into a vapor capable of passing from the second cavity, through the barrier, and into the first cavity where the vapor can activate the coating. As a result, the vapor produced when the liquid changes phase causes the coating on the catheter to be activated to thereby produce the low-friction surface on the catheter so it is ready-to-use when it reaches the end user. | 05-21-2009 |
20100263327 | CATHETER PRODUCT PACKAGE AND METHOD OF FORMING SAME - A catheter product package and method of forming same in which the package comprises a sheet material wrapped about the catheter product to form a package for the catheter product. The catheter product extends generally longitudinally within the package, and the sheet material extends from a point beyond the proximal end to a point beyond the distal end of the catheter product. The sheet material of the package is wrapped about the catheter product in a manner defining confronting proximal end edges, confronting distal end edges, and confronting side edges. The confronting proximal end edges, distal end edges and side edges of the sheet material are joined by a seal after the sheet material is wrapped about the catheter product to define a sealed cavity. The sheet material has a tear strip affixed to it which causes the sheet material to tear along the tear strip to thereby cause the package to open along an intended opening line. A method of forming a package for a catheter product comprises the steps of providing a sheet material for the package and placing the catheter product on the sheet material. It also includes affixing a tear strip to the sheet material and wrapping the sheet material around the catheter product. Further, the method includes the step of sealing the sheet material to form a sealed cavity with the catheter product being disposed within the sealed cavity. | 10-21-2010 |
20100305527 | CATHETER PRODUCT PACKAGE AND METHOD OF FORMING SAME - A catheter product package and method of forming same in which the package comprises a sheet material wrapped about the catheter product to form a package for the catheter product. The catheter product extends generally longitudinally within the package, and the sheet material extends from a point beyond the proximal end to a point beyond the distal end of the catheter product. The sheet material of the package is wrapped about the catheter product in a manner defining confronting proximal end edges, confronting distal end edges, and confronting side edges. The confronting proximal end edges, distal end edges and side edges of the sheet material are joined by a seal after the sheet material is wrapped about the catheter product to define a sealed cavity. The sheet material has a tear strip affixed to it which causes the sheet material to tear along the tear strip to thereby cause the package to open along an intended opening line. A method of forming a package for a catheter product comprises the steps of providing a sheet material for the package and placing the catheter product on the sheet material. It also includes affixing a tear strip to the sheet material and wrapping the sheet material around the catheter product. Further, the method includes the step of sealing the sheet material to form a sealed cavity with the catheter product being disposed within the sealed cavity. | 12-02-2010 |
20130146599 | CATHETER PRODUCT PACKAGE AND METHOD OF FORMING SAME - A catheter product package and method of forming same in which the package comprises a sheet material wrapped about the catheter product to form a package for the catheter product. The catheter product extends generally longitudinally within the package, and the sheet material extends from a point beyond the proximal end to a point beyond the distal end of the catheter product. The sheet material of the package is wrapped about the catheter product in a mariner defining confronting proximal end edges, confronting distal end edges, and confronting side edges. The confronting proximal end edges, distal end edges and side edges of the sheet material are joined by a seal after the sheet material is wrapped about the catheter product to define a sealed cavity. The sheet material has a tear strip affixed to it which causes the sheet material to tear along the tear strip to thereby cause the package to open along an intended opening line. A method of forming a package for a catheter product comprises the steps of providing a sheet material for the package and placing the catheter product on the sheet material. It also includes affixing a tear strip to the sheet material and wrapping the sheet material around the catheter product. Further, the method includes the step of sealing the sheet material to form a sealed cavity with the catheter product being disposed within the sealed cavity. | 06-13-2013 |
Kaj Anker Jorgensen, Langa DK
Patent application number | Description | Published |
---|---|---|
20080306154 | Treatment and prevention of major adverse cardiovascular events or major coronary evens by administering Omega-3 fatty acids - Omega-3 fatty acid compositions comprising eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are provided, where the compositions are useful for treating, reducing the occurrence of, or preventing major adverse cardiovascular events or major coronary events in patients who have established cardiovascular disease without prior myocardial infarction, preventing their further progression, and treating underlying risk factors for CVD such as hypertension, dyslipidemia, obesity and/or diabetes. | 12-11-2008 |
20110092552 | Treatment and Prevention of Major Adverse Cardiovascular Events or Major Coronary Events by Administering Omega-3 Fatty Acids - Omega-3 fatty acid compositions comprising eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are provided, where the compositions are useful for treating, reducing the occurrence of, or preventing major adverse cardiovascular events or major coronary events in patients who have established cardiovascular disease without prior myocardial infarction, preventing their further progression, and treating underlying risk factors for CVD such as hypertension, dyslipidemia, obesity and/or diabetes. | 04-21-2011 |
Klas Jorgensen, Odense DK
Patent application number | Description | Published |
---|---|---|
20090266363 | Respiration valve - The present invention relates to a respiration valve ( | 10-29-2009 |
Kristian Skovgaard Jorgensen, Roskilde DK
Patent application number | Description | Published |
---|---|---|
20110281060 | FLEXIBLE INSULATING PRODUCT - A flexible heat insulation product ( | 11-17-2011 |
20130119294 | Method for Manufacturing an Aerogel-Containing Composite and Composite Produced by that Method - Method for manufacturing an aerogel-containing composite, said method comprising the steps of: providing fibres, at least some of which are first fibres, such as mineral fibres, polymer fibres, cellulose fibres, or other types of fibres, in an amount of from 3 to 80 wt % of the total weight of starting materials, providing an aerogel particulate material in an amount of from 10 to 75 wt % of the total weight of starting materials, providing a binder in an amount of from 1 to 30 wt % of the total weight of starting materials, suspending the fibres in a primary air flow and suspending the aerogel particulate material in the primary air flow, thereby mixing the suspended aerogel particulate material with the suspended fibres, mixing the binder with the fibres and/or aerogel particulate material before, during or after mixing of the fibres with the aerogel particulate material, providing a filler, such as a fire retardant, in an amount of 1 to 55 wt of the total weight of starting materials, adding the filler at any suitable step of the method, such as before, during or after mixing of the fibres with the aerogel particulate material, collecting the mixture of fibres, aerogel particulate material, filler and binder and pressing and curing the mixture to provide a consolidated composite with a density of from 120 kg/m | 05-16-2013 |
20130221567 | Method for Manufacturing a Fibre-Containing Element and Element Produced by that Method - A method for manufacturing a fibre-containing element, said method comprising the steps of: providing fibres, at least some of which are first fibres, such as mineral fibres, polymer fibres, cellulose fibres, or other types of fibres, in an amount of from 3 to 98 wt % of the total weight of starting materials in the form of a collected web, providing a binder in an amount of from 1 to 30 wt % of the total weight of starting materials, subjecting the collected web of fibres to a disentanglement process, suspending the fibres in a primary air flow, mixing the binder with the fibres before, during or after the disentanglement process, providing a filler, such as a fire retardant, in an amount of 1 to 55 wt % of the total weight of starting materials, adding the filler at any suitable step of the method, such as before, during or after the dientanglement process, collecting the mixture of fibres, filler and binder and pressing and curing the mixture to provide a consolidated composite with a density of from 120 kg/m | 08-29-2013 |
20140001676 | METHOD FOR MANUFACTURING A MINERAL FIBRE-CONTAINING ELEMENT AND ELEMENT PRODUCTED BY THAT METHOD | 01-02-2014 |
Kristian Skovgard Jorgensen, Roskilde DK
Patent application number | Description | Published |
---|---|---|
20120187323 | METHOD FOR MANUFACTURING AN AEROGEL-CONTAINING COMPOSITE AND COMPOSITE PRODUCED BY THAT METHOD - The invention relates to a method for manufacturing an insulating composite containing mineral fibers, aerogel and binder. This method implies the step of suspending the fiber webs and aerosol in an air flow thereby disentangling the fiber webs and mixing fibers, aerosol and eventually binder homogeneously. The apparatus described combines spinning of the fibers, collecting them as webs, disentangling the fiber webs in suspended air, mixing the fibers with aerogel and cement as well as pressing and curing the mixture to a consolidated product of density 150 to 800 kg/m | 07-26-2012 |
Kristian Vang Jorgensen, Lyngby DK
Patent application number | Description | Published |
---|---|---|
20130271548 | PRINTING APPARATUS - The invention provides a method of controlling the pressure applied to a substrate being printed by a thermal transfer printing head. The head displacement facility includes a resilient member such as a spring which undergoes deflection as the print head engages the substrate. The method comprises monitoring both print head position and spring deflection to control the pressure applied by the print head. | 10-17-2013 |
Lone Norgaard Jorgensen, Birkerod DK
Patent application number | Description | Published |
---|---|---|
20090017125 | Drug carrier pellet production process - The invention provides a process for the production of drug carrier pellets comprising spray-dried pellets comprising spray-drying a solution of a physiologically tolerable cellulosic binder containing a physiologically tolerable inert particulate carrier having a particle size D (v.0.5) of less than 50 μm. | 01-15-2009 |
Louise Jorgensen, Horsholm DK
Patent application number | Description | Published |
---|---|---|
20090324628 | COMPOUNDS USEFUL IN THE DIAGNOSIS AND TREATMENT OF MALARIA - The present invention relates to nucleic acid molecules related to the PFD1235w/MAL7P1.1, PF11_0008, and PF13_0003 gene families as well as amino acid sequences encoded by such nucleic acid molecules with respect to their role in mediating adhesion of infected red blood cells to endothelial cells, which is characteristic for the pathogenesis of severe malaria (SM). Accordingly, the invention provides pharmaceutical compositions and vaccines, hereunder nucleotide-based vaccines comprising compounds that are related to VAR4, VAR5, and/or VAR6 polypeptides and PFD1235w/MAL7P1.1 PF11_0008, and/or PF13_0003 nucleic acid molecules. The invention further relates to the use of these compounds as medicaments and for the manufacture of compositions, such as immunogenic compositions. In addition, the invention relates to methods of treatment and prevention of severe malaria wherein these methods are based on the nucleic acid molecules and polypeptides of the invention. As these compounds can also be used as biotechnological tools the invention provides in vitro diagnostic methods and kits comprising reagents and IgGs/antibodies designated to the use in such methods. The invention also relates to methods of identifying agents capable of modulating the VAR4, VAR5, and/or VAR6 dependent adhesion to endothelial cells and agent capable of interacting with VAR4, VAR5, and/or VAR6. Finally, a method for identifying polypeptides, which will induce a specific IgG/antibody response upon administration to a subject is provided by the invention. | 12-31-2009 |
Malene Ryborg Jorgensen, Copenhagen DK
Patent application number | Description | Published |
---|---|---|
20080227092 | Solid-Phase Oligosaccharide Tagging: a Technique for Manipulation of Immobilized Carbohydrates - The invention relates to methods of manipulating immobilised carbohydrates by derivatisation. Depending on the nature of the derivatisation, the carbohydrate may thereby be more easily detected and/or identified or handled. In particular, the invention relates to methods of preparing a reactive sugar comprising the steps of: i) providing a sample comprising a reducing sugar; ii) providing a solid support covalently attached to a linker comprising a capture group comprising an —NH2 group, wherein said linker optionally is attached to said solid support via a spacer; iii) reacting said reducing sugar with said —NH2 group, thereby obtaining an immobilised sugar; iv) reacting free —NH2 groups with a capping agent, wherein the capping agent comprises a reactive group capable of reacting with an —NH2 group; and v) reducing C═N bonds with a reducing agent, thereby obtaining an reactive sugar of the structure SugarCH | 09-18-2008 |
Martin Jorgensen, Hovedgard DK
Patent application number | Description | Published |
---|---|---|
20100283245 | WIND TURBINE - For optimising annual energy production in a wind turbine, the invention provides a method by which operation of the turbine in accordance with different pre-specified modes depending on the wind direction towards the turbine is enabled. The modes may include pitch and/or power control strategies. The invention further provides a control system for a wind turbine adapted to operate in accordance with the method, and a wind turbine with such a control system. | 11-11-2010 |
Martin Bondo Jorgensen, Vaerlose DK
Patent application number | Description | Published |
---|---|---|
20080287826 | Transport System for Biopsy Device - A biopsy device for harvesting tissue samples from a body of a living being, e.g. in percutaneous aspiration biopsy, includes an outer needle and a sample-receiving device for receiving a severed tissue sample, the sample-receiving device being movable in the hollow needle. The device includes a transport device for moving the sample-receiving device in the hollow needle, the transport device comprising a bendable elongate element, such as a steel wire, a toothed wire made from e.g. a plastics material or a Bowden cable capable of pushing and pulling the sample-receiving device in distal and proximal directions, respectively. A coiling device is provided for the bendable elongate element. The bendable elongate element and the coiling device may be included in a disposable unit, which is attachable to a hand-held unit including a motor for driving the transport device. Orientation means are provided for appropriately orienting the sample-receiving device with respect to the hollow needle. | 11-20-2008 |
20090059725 | Electroacoustic transducer having a slotted terminal structure for connection to a flexible wire, and an assembly of the same - The assembly includes a miniature electroacoustic transducer and a flexible electrical wire. The flexible electrical wire is terminated by a connecting element with an electrically conductive shoulder portion. The miniature electroacoustic transducer comprises an electrically conducting, externally accessible terminal having a slot structure formed therein. The slot structure is configured to mechanically and electrically engage the electrically conductive shoulder portion of the connecting element. | 03-05-2009 |
20090154749 | DETACHABLE EARPIECE AUDITORY DEVICE WITH SPRING OPERATION - A detachable earpiece auditory device comprises a housing, a speaker, and a connector. The housing has a sound outlet, a second opening, and a spring element positioned at the second opening. The speaker is provided within the housing and comprises an electrically conducting speaker terminal at an outer surface of the speaker. The connector comprises a first insert part, an electrically conducting connector terminal, and a second insert part. The first insert part is insertable into the second opening. The electrically conducting connector terminal is positioned in the first insert part to obtain electrical contact with the electrically conducting speaker terminal and forms a mating pair of a speaker terminal and a connector terminal when the first insert part is inserted into the second opening. The second insert part operatively contacts the spring element to bias the speaker terminal against the connector terminal with a predetermined bias force. | 06-18-2009 |
20120184873 | TISSUE SAMPLE FLUSHING SYSTEM FOR BIOPSY DEVICE - A self-contained hand-held biopsy device includes a hollow needle having a distal end portion with a circumferential cutting edge. A sample-receiving device is received in the hollow needle, and has a tapered distal tip and a cavity configured to receive a tissue sample. The sample-receiving device is configured to move in the hollow needle between a first extended position and a second retracted position. A transport device is configured to move the sample-receiving device relative to the hollow needle. A liquid supply unit is configured to operatively connect to the cavity of the sample-receiving device when the sample-receiving device is in the second retracted position and is configured to deliver a flow of the flushing liquid to the cavity to facilitate tissue sample ejection from the cavity. The liquid supply unit is disconnected from the cavity of the sample-receiving device when the sample-receiving device is in the first extended position. | 07-19-2012 |
Michael Frounberg Jorgensen, Allerod DK
Patent application number | Description | Published |
---|---|---|
20140128767 | EAR COUPLER - An ear coupler includes: a member having a cavity for accommodating at least a part of an ear; and a structure extending from the member, the structure having an end with a port; wherein the port is configured for detachably coupling to a transducer. | 05-08-2014 |
Mikkel Jorgensen, Glostrup DK
Patent application number | Description | Published |
---|---|---|
20130277669 | ELECTRON TRANSPORT LAYER - The present invention provides: a method of preparing a coating ink for forming a zinc oxide electron transport layer, comprising mixing zinc acetate and a wetting agent in water or methanol; a coating ink comprising zinc acetate and a wetting agent in aqueous solution or methanolic solution; a method of preparing a zinc oxide electron transporting layer, which method comprises: i) coating a substrate with the coating ink of the present invention to form a film; ii) drying the film; and iii) heating the dry film to convert the zinc acetate substantially to ZnO; a method of preparing an organic photovoltaic device or an organic LED having a zinc oxide electron transport layer, the method comprising, in this order: a) providing a substrate bearing a first electrode layer; b) forming an electron transport layer according to the following method: i) coating a coating ink comprising an ink according to the present invention to form a film; ii) drying the film; iii) heating the dry film such that the zinc acetate is substantially converted to ZnO; c) forming an active layer; d) forming a hole transport layer; and e) forming a second electrode layer; and an optoelectronic device comprising an electron transporting layer comprising zinc oxide and a wetting agent. | 10-24-2013 |
Niels Jorgensen, Copenhagen S DK
Patent application number | Description | Published |
---|---|---|
20130045890 | TEST FOR MALE FERTILITY - The present invention relates generally to a method for predicting the fertility potential in a male mammal. In particular it relates to a method for predicting the fertility potential in a male mammal by determining the expression of at least one protein of the vitamin D metabolising machinery in a semen sample. The expression level of the at least one protein of the vitamin D metabolising machinery is then indicative of the fertility potential of the subject. An object of the present invention relates to a method, which can predict whether the semen quality is sufficient to achieve pregnancy spontaneously or if the couple should proceed to assisted reproduction or further investigation. | 02-21-2013 |
Niels Erik Jorgensen, Greve DK
Patent application number | Description | Published |
---|---|---|
20090010403 | Method for Minimizing Message Collision in a Device - A method for minimizing message collision in a device is presented. Two or more overlapping real-time streaming simplex audio messages are received. One of the audio messages is forwarded to be reproduced while the other is stored. Forwarding of the delayed audio message is delayed such that overlapping reproduction of the audio messages is minimized. Reproduction is delayed until a predetermined clock time expires or is dependent on one or more of: the length of the second audio message or the amount of overlap of the first and second audio messages. | 01-08-2009 |
20090054098 | METHOD AND MOBILE STATION FOR AUTOMATIC CREATION OF TALK GROUP - A method of automatic creation of a talk group in a wireless radio communication system comprising a plurality of mobile stations, said method comprising the steps of: transmitting by a first mobile station an emergency message containing at least its ID and localization data; transmitting by other mobile stations their IDs and localization data in response to said emergency message; creating said talk group by selecting those mobile stations which transmitted their IDs and localization data. | 02-26-2009 |
20120201364 | METHOD FOR MINIMIZING MESSAGE COLLISION IN A DEVICE - A method for minimizing message collision in a device is presented. Two or more overlapping real-time streaming simplex audio messages are received. One of the audio messages is forwarded to be reproduced while the other is stored. Forwarding of the delayed audio message is delayed such that overlapping reproduction of the audio messages is minimized. Reproduction is delayed until a predetermined clock time expires or is dependent on one or more of: the length of the second audio message or the amount of overlap of the first and second audio messages. | 08-09-2012 |
20120214535 | METHOD AND MOBILE STATION FOR AUTOMATIC CREATION OF TALK GROUP - A method of automatic creation of a talk group in a wireless radio communication system comprising a plurality of mobile stations, said method comprising the steps of: transmitting by a first mobile station an emergency message containing at least its ID and localization data; transmitting by other mobile stations their IDs and localization data in response to said emergency message; creating said talk group by selecting those mobile stations which transmitted their IDs and localization data. | 08-23-2012 |
Ole Jorgensen, Slagelse DK
Patent application number | Description | Published |
---|---|---|
20080245428 | Control Valve - A control valve for use in a liquid-carrying system, such as a heating or cooling system, containing a differential pressure governor which keeps the differential pressure between the inlet and the outlet constant. The control valve also includes an arrangement for setting and adjusting the maximum flow of liquid through the valve. This arrangement comprises a flow valve having two cooperating valve members ( | 10-09-2008 |
Per Buchard Jorgensen, Vaerlose DK
Patent application number | Description | Published |
---|---|---|
20120137468 | HANDLE FOR A HOUSING FOR A PORTABLE X-RAY DEVICE - A handle for a housing of a portable X-ray device includes an annular base body. The annular base body includes a holding part and a mounting part. A mounting device is disposed in the mounting part and includes two wheels spaced apart from one another on a common axle and a recess between the two wheels, wherein the two wheels protrude beyond an outer contour of the annular base body. Connecting straps are disposed on the holding part and configured to connect the annular base body to the housing. | 06-07-2012 |
Per Lina Jorgensen, Copenhangen K DK
Patent application number | Description | Published |
---|---|---|
20120079665 | FAMILY 44 XYLOGLUCANASES - The present invention relates to xyloglucanases belonging to family 44 of glycosyl hydrolases and having a relative xyloglucanase activity of at least 30% between pH 5 and pH 8 are derived from the genus | 04-05-2012 |
Per Lina Jorgensen, Copenhagen K DK
Patent application number | Description | Published |
---|---|---|
20100212091 | FAMILY 44 XYLOGLUCANASES - The present invention relates to xyloglucanases belonging to family 44 of glycosyl hydrolases and having a relative xyloglucanase activity of at least 30% between pH 5 and pH 8 are derived from the genus | 08-26-2010 |
Per Lina Jorgensen, Copenhagen DK
Patent application number | Description | Published |
---|---|---|
20130086755 | Family 44 Xyloglucanases - The present invention relates to xyloglucanases belonging to family 44 of glycosyl hydrolases and having a relative xyloglucanase activity of at least 30% between pH 5 and pH 8 are derived from the genus | 04-11-2013 |
Per Trolle Jorgensen, Odense DK
Patent application number | Description | Published |
---|---|---|
20110130557 | INTERCALATING TRIPLEXES AND DUPLEXES USING ARYL NAPHTHOIMIDAZOL AND PROCESS FOR THE PREPARATION THEREOF - There is provided an intercalating oligonucleotide for stabilizing natural or modified DNA and RNA triplexes, duplexes and hybrids thereof having the general structure (I) triplex forming oligonucleotides of the invention are capable of binding specifically to double stranded target nucleic acids and are therefore of interest for modulation of the activity of target nucleic acids and also detection of target nucleic acids. | 06-02-2011 |
Rasmus Jorgensen, Maaloev DK
Patent application number | Description | Published |
---|---|---|
20130040877 | LONG-ACTING Y2 RECEPTOR AGONISTS - The present invention relates to PYY analogues or derivatives thereof comprising at least one alteration selected from the group consisting of substitutions, insertions, deletions and modifications and optionally a serum albumin binding side chain comprising an alkyl chain with at least 14 carbon atoms. Moreover, the invention relates to compositions hereof and methods of treatment of conditions responsive to Y2 receptor modulation. | 02-14-2013 |
Rasmus Nyholm Jorgensen, Haldrup DK
Patent application number | Description | Published |
---|---|---|
20110024219 | OMNI ROTATIONAL DRIVING AND STEERING WHEEL - There is disclosed a driving and steering wheel ( | 02-03-2011 |
Rolf B. Jorgensen, Graested DK
Patent application number | Description | Published |
---|---|---|
20080202407 | Theft Deterrent System and a Device For Use in Said System - The invention concerns a theft deterrent device ( | 08-28-2008 |
Soren Michael Juul Jorgensen, Odense S DK
Patent application number | Description | Published |
---|---|---|
20090199733 | Apparatus for forming a printing form having a cylindrical support - The invention pertains to an apparatus and a process for forming a printing form from a photosensitive element having a cylindrical support, and in particular, to an apparatus and a process for thermally treating the photosensitive element to form a relief pattern and particularly to form a cylindrically-shaped flexographic printing form. The apparatus and process includes supporting the cylindrical support to accommodate thermal treating of photosensitive elements with various sizes of the cylindrical support. | 08-13-2009 |
Steen Troels Jorgensen, Alleroed DK
Patent application number | Description | Published |
---|---|---|
20090280569 | Chloramphenicol Resistance Selection in Bacillus Licheniformis - The present invention relates to a modified | 11-12-2009 |
20130210152 | Chloramphenicol Resistance Selection in Bacillus Licheniformis - The present invention relates to a modified | 08-15-2013 |
Steen Troels Jorgensen, Allerod DK
Patent application number | Description | Published |
---|---|---|
20090176290 | Bacillus Host Cell | 07-09-2009 |
20090203074 | Bacillus Host Cell | 08-13-2009 |
20100120623 | Selection of Well-Expressed Synthetic Genes - The invention relates to a method of indirectly identifying a polynucleotide comprising an open reading frame having an improved expression level from a library of polynucleotides encoding the same polypeptide of interest, or variants or homologues thereof, in a host cell expression library, the method comprising the steps of: a) providing an expression library in a host cell, said library comprising at least two different open reading frames encoding the same polypeptide of interest, or variants or homologues thereof, each open reading frame being translationally coupled to a downstream gene encoding a screenable or selectable reporter; b) culturing the host cell under conditions conducive to the expression of the polypeptide of interest, or variant or homologue thereof; and c) screening and/or selecting for a host cell having an improved expression level of the translationally coupled reporter when compared to one or more other host cells of the library, thus indirectly identifying a polynucleotide comprising an open reading frame having an improved expression level in the host cell; as well as the expression libraries and host cells comprising said libraries. | 05-13-2010 |
20140106457 | Stably maintained multiple copies of at least two ORF in the same orientation - The present invention relates to a method for constructing a host cell expressing a polypeptide of interest from at least two ORF's stably integrated onto the chromosome of the host cell comprising the steps of: | 04-17-2014 |
Susanne Jorgensen, Frederiksberg DK
Patent application number | Description | Published |
---|---|---|
20100029685 | OXADIAZOLE AND THIADIAZOLE COMPOUNDS AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS - This invention relates to oxadiazolyl and thiadiazolyl derivatives, which are found to be modulators of the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances. | 02-04-2010 |
Thomas Friis Jorgensen, Holbaek DK
Patent application number | Description | Published |
---|---|---|
20090100757 | Chain operator housing - A stop member for an operator chain in a chain operator, wherein the operator chain has a width, rivet holes and rivets, constitutes a pin arranged in a rivet hole not occupied by a rivet in the operator chain, wherein the pin has a length exceeding the width of the operator chain. The pin can be cylindrical with a diameter corresponding essentially to that of the rivet hole, and the diameter of the pin can be slightly smaller than that of the rivet hole, so as to be loosely held in the rivet hole. | 04-23-2009 |
Tina Jorgensen, Silkeborg DK
Patent application number | Description | Published |
---|---|---|
20130040328 | ASSAY FOR PHYTOL-FREE CHLOROPHYLL DERIVATIVES - The present invention provides a method for detecting a phytol-free chlorophyll derivative in a sample, comprising a step of detecting a fluorescent signal associated with the phytol-free chlorophyll derivative, wherein a fluorescent signal associated with chlorophyll or a phytol-containing chlorophyll derivative in the sample is quenched. The method may be used for quantifying activity of chlorophyllases and related enzymes in a sample without solvent fractionation of substrate and product. | 02-14-2013 |
Tina Lilian Jorgensen, Silkeborg DK
Patent application number | Description | Published |
---|---|---|
20130085287 | PROCESS - In one aspect the present invention provides a process for treating oil-containing seeds, comprising a step of contacting the seeds with an enzyme which is capable of hydrolysing chlorophyll or a chlorophyll derivative. Also provided are a method for obtaining oil from plant seeds and a process for producing a refined plant oil comprising such a treatment. Further provided are crude and refined plant oils obtainable from the processes and methods. | 04-04-2013 |
Tina Lillan Jorgensen, Silkeborg DK
Patent application number | Description | Published |
---|---|---|
20130330804 | PROCESS - In one aspect, there is provided a process for treating a plant oil, comprising a step of contacting the oil with an enzyme, wherein the enzyme is capable of hydrolysing an a′ or b′ stereoisomer of chlorophyll or a chlorophyll derivative. | 12-12-2013 |
20140363877 | PROCESS - In one aspect, there is provided a process for treating a plant oil, comprising a step of contacting the oil with an enzyme, wherein the enzyme is capable of hydrolysing an a′ or b′ stereoisomer of chlorophyll or a chlorophyll derivative. | 12-11-2014 |
Tino Dyhring Jorgensen, Ballerup DK
Patent application number | Description | Published |
---|---|---|
20080227772 | Diazabicyclic Aryl Derivatives as Nicotinic Acetylcholine Receptor Ligands - This invention relates to novel diazabicyclic aryl derivatives which are found to be cholinergic ligands at the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances. | 09-18-2008 |
20080227773 | Diazabicyclic Aryl Derivatives as Cholinergic Receptor Modulators - This invention relates to novel diazabicyclic aryl derivatives which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemicals substances. | 09-18-2008 |
20080242668 | Dimeric Azacyclic Compounds and Their Use - This invention relates to azacyclic derivatives according of formula (I) and their use as pharmaceuticals. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or. disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the′ termination of abuse of chemical substances. Formula (I) Aza-X′-A′-Y′-L-Y-A″-X″-Aza Aza:Azabicyclic group A′,A″:Aromatic monocyclic and/or polycyclic, carbocyclic and/or heterocyclic group Y′,Y″: Linker or absent (covalent bond) L: Monocyclic or polycyclic, carbocyclic or heterocyclic group or is absent X′,X″: Linker or absent (covalent bond) | 10-02-2008 |
20090005390 | NOVEL QUINUCLIDINE DERIVATIVES AND THEIR USE - This invention relates to novel quinuclidine derivatives and their use as pharmaceuticals. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances. | 01-01-2009 |
Tomas M. Jorgensen, Silkeborg DK
Patent application number | Description | Published |
---|---|---|
20100078284 | TORQUE TRANSFERRING ARRANGEMENT - A torque transferring arrangement ( | 04-01-2010 |
Torben Jorgensen, Herlev DK
Patent application number | Description | Published |
---|---|---|
20090096618 | OIL LEAKAGE DETECTOR - An oil leakage detector for detecting the leakage of e.g. diesel or fuel oil in an engine room of a vessel comprises a conduit for an airflow therethrough, and a screen in the conduit. The screen is meshed to prevent oil particles or droplets from passing therethrough. A sensor determines a pressure loss across the screen, and a control system operatively connected to the sensor is configured to output an oil leakage warning signal if the pressure loss exceeds a predetermined threshold value. A fan may be provided for generating the airflow through the conduit. A gas sensor for determining the presence of hydrocarbon, carbon monoxide or carbon dioxide is optionally provided. | 04-16-2009 |
Vivi Bjerre Jorgensen, Odense M DK
Patent application number | Description | Published |
---|---|---|
20140261505 | Nicotine Chewing Gum With Improved Utilization Of Nicotine - The invention relates to chewing gums for the delivery of nicotine, wherein the average pH in the mouth of individuals chewing the chewing gum, in the time period from 3 to 7 minutes from the onset of chewing, is within the interval of 8.5 to 9. | 09-18-2014 |